Mirador Therapeutics, Inc. has raised $413.0M in total funding.
Mirador Therapeutics, Inc. is headquartered in San Diego, CA.
Today's treatments for immune-mediated inflammatory and fibrotic (I&I) diseases are hitting an efficacy ceiling.
Mirador takes a precision-first drug discovery and development approach to identify the right therapeutic targets and the right patients for immuno-fibrotic diseases.
Its proprietary Mirador360 platform is described as an end-to-end precision discovery engine that combines multi-modal data, AI, and advanced analytics to identify novel targets, select optimal combination therapies, and pinpoint likely responders.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.